ABOUT
Who We Are
Our Team
The Toronto Advantage
Our Strategy
Our Success Stories
Policies
Awards
Careers
Accelerator Fund
For Researchers
UHN Community
Academic Partners
For Industry
Our Philosophy
UHN Opportunity
Collaborating With Researchers
Resources
For Investors
New Ventures
Our Companies
Our New Venture Model
Resources
News & Events
Contact
2021 Archived news
March 3, 2021
-
World-first: Pilot study treating Fabry disease with gene therapy receives promising results
April 23, 2021
-
From discovery to drug development on home turf
April 27, 2021
-
Jump-starting memory with DBS
June 22, 2021
-
UHN launches start-up to advance blood-based precision medicine
July 8, 2021
-
The Ontario government awards UHN over $3.8 million for cutting-edge research
September 22, 2021
-
Lucid Psycheceuticals Acquired by FSD Pharma to further develop UHN MS therapy platform
November 1, 2021
-
University Health Network reported top Canadian research commercialization institution for 2nd year running
November 18, 2021
-
Treadwell Therapeutics' Series B set to fund clinical development of UHN's cancer fighting assets.
December 1, 2021
-
Krembil's annual report features commercialization partnership
Back to News